Artículos de revistas sobre el tema "Drug-reduced regimens"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Drug-reduced regimens".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
VanScoy, Brian, Jennifer McCauley, Sujata M. Bhavnani, Evelyn J. Ellis-Grosse y Paul G. Ambrose. "Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model". Antimicrobial Agents and Chemotherapy 60, n.º 9 (6 de junio de 2016): 5141–45. http://dx.doi.org/10.1128/aac.00355-16.
Texto completoAng, Zen Yang, Kit Yee Cheah, Nadiah B. Abdullah, Safawati B. Samsuri, Siao Hui Lee, Andrew WH Yem y Malathi AP Sriraman. "Parenteral cytotoxic drug wastage at a tertiary hospital in Kuala Lumpur: How much and why?" Journal of Oncology Pharmacy Practice 26, n.º 6 (6 de diciembre de 2019): 1306–17. http://dx.doi.org/10.1177/1078155219891209.
Texto completoVia, Laura E., Kathleen England, Danielle M. Weiner, Daniel Schimel, Matthew D. Zimmerman, Emmanuel Dayao, Ray Y. Chen et al. "A Sterilizing Tuberculosis Treatment Regimen Is Associated with Faster Clearance of Bacteria in Cavitary Lesions in Marmosets". Antimicrobial Agents and Chemotherapy 59, n.º 7 (4 de mayo de 2015): 4181–89. http://dx.doi.org/10.1128/aac.00115-15.
Texto completoRhee, Soo-Yon, Philip M. Grant, Philip L. Tzou, Geoffrey Barrow, P. Richard Harrigan, John P. A. Ioannidis y Robert W. Shafer. "A systematic review of the genetic mechanisms of dolutegravir resistance". Journal of Antimicrobial Chemotherapy 74, n.º 11 (5 de julio de 2019): 3135–49. http://dx.doi.org/10.1093/jac/dkz256.
Texto completoTasneen, Rokeya, Fabrice Betoudji, Sandeep Tyagi, Si-Yang Li, Kathy Williams, Paul J. Converse, Véronique Dartois et al. "Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis". Antimicrobial Agents and Chemotherapy 60, n.º 1 (26 de octubre de 2015): 270–77. http://dx.doi.org/10.1128/aac.01691-15.
Texto completoHawkins, Trevor, Wenoah Veikley, Lucie Durand-Gasselin, Darius Babusis, Y. Sunila Reddy, John F. Flaherty y Adrian S. Ray. "Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients". Antimicrobial Agents and Chemotherapy 55, n.º 4 (31 de enero de 2011): 1549–55. http://dx.doi.org/10.1128/aac.00910-10.
Texto completoZhdanov, Konstantin V., Oleg V. Maltsev, Kristina V. Kasyanenko, Konstantin V. Kozlov, Vitalii S. Sukachev, Nikolai I. Lvov, Valerian V. Sharabkhanov y Alexander A. Litvinov. "Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults". Terapevticheskii arkhiv 95, n.º 11 (22 de diciembre de 2023): 930–36. http://dx.doi.org/10.26442/00403660.2023.11.202471.
Texto completoDutta, Noton K., Michael L. Pinn y Petros C. Karakousis. "Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis". Antimicrobial Agents and Chemotherapy 58, n.º 7 (5 de mayo de 2014): 4048–53. http://dx.doi.org/10.1128/aac.02981-14.
Texto completoJung, H., R. Medina, N. Castro, T. Corona y J. Sotelo. "Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen." Antimicrobial Agents and Chemotherapy 41, n.º 6 (junio de 1997): 1256–59. http://dx.doi.org/10.1128/aac.41.6.1256.
Texto completoTyczyńska, Agata, Marcela Krzysława Krzempek, Alexander Jorge Cortez, Artur Jurczyszyn, Katarzyna Godlewska, Hanna Ciepłuch, Edyta Subocz et al. "The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age". Cancers 15, n.º 13 (2 de julio de 2023): 3469. http://dx.doi.org/10.3390/cancers15133469.
Texto completoJung, Hyun Joo y Nami McCarty. "Stem-Like Tumor Cells Confer Drug Resistant Properties to Mantle Cell Lymphoma". Blood 116, n.º 21 (19 de noviembre de 2010): 1840. http://dx.doi.org/10.1182/blood.v116.21.1840.1840.
Texto completoCórdoba, J., N. M. Coronado-Álvarez, D. Parra y J. Parra-Ruiz. "In VitroActivities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii". Antimicrobial Agents and Chemotherapy 59, n.º 12 (14 de septiembre de 2015): 7316–19. http://dx.doi.org/10.1128/aac.00493-15.
Texto completoLubberman, Floor, Hans Gelderblom, Paul Hamberg, Walter Vervenne, Sasja F. Mulder, Frank Jansman, Angela Colbers et al. "A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs?" Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 4564. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4564.
Texto completoShank, Kaitlyn R., Priya Koppikar, Neha Bhagwat, Matthew D. Keller, Franziska Michor, Ross L. Levine y Laura De Vargas Roditi. "Mathematical Optimization of JAK Inhibitor Dose and Scheduling for MPN Patients". Blood 124, n.º 21 (6 de diciembre de 2014): 911. http://dx.doi.org/10.1182/blood.v124.21.911.911.
Texto completoBhatti, Laveeza y Jay Gladstein. "Once-Daily Nevirapine XR". Journal of the International Association of Physicians in AIDS Care 11, n.º 6 (27 de agosto de 2012): 369–73. http://dx.doi.org/10.1177/1545109712456427.
Texto completoRao, Gauri G., Neang S. Ly, Curtis E. Haas, Samira Garonzik, Alan Forrest, Jurgen B. Bulitta, Pamela A. Kelchlin et al. "New Dosing Strategies for an Old Antibiotic: Pharmacodynamics of Front-Loaded Regimens of Colistin at Simulated Pharmacokinetics in Patients with Kidney or Liver Disease". Antimicrobial Agents and Chemotherapy 58, n.º 3 (16 de diciembre de 2013): 1381–88. http://dx.doi.org/10.1128/aac.00327-13.
Texto completoHenegar, Cassidy, Emilio Letang, Ruolan Wang, Charles Hicks, Dainielle Fox, Bryn Jones, Annemiek de Ruiter y Vani Vannappagari. "A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings". Viruses 15, n.º 12 (14 de diciembre de 2023): 2426. http://dx.doi.org/10.3390/v15122426.
Texto completoSvensson, Elin M., Francesca Aweeka, Jeong-Gun Park, Florence Marzan, Kelly E. Dooley y Mats O. Karlsson. "Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis". Antimicrobial Agents and Chemotherapy 57, n.º 6 (9 de abril de 2013): 2780–87. http://dx.doi.org/10.1128/aac.00191-13.
Texto completoCraddock, Charles. "Pharmacological methods to reduce disease recurrence". Hematology 2013, n.º 1 (6 de diciembre de 2013): 63–69. http://dx.doi.org/10.1182/asheducation-2013.1.63.
Texto completoAziz, Muhammad Tahir. "Drug Interaction Exposures in an Intensive Care Unit: AntihypertensivePopulation". Journal of Applied Pharmacy 7 (2015): 41. http://dx.doi.org/10.21065/19204159.7.41.
Texto completoGonzalez-Juarrero, Mercedes, Lisa K. Woolhiser, Elizabeth Brooks, Mary Ann DeGroote y Anne J. Lenaerts. "Mouse Model for Efficacy Testing of Antituberculosis Agents via Intrapulmonary Delivery". Antimicrobial Agents and Chemotherapy 56, n.º 7 (30 de abril de 2012): 3957–59. http://dx.doi.org/10.1128/aac.00464-12.
Texto completoLu, Hong y Sara Rosenbaum. "Developmental Pharmacokinetics in Pediatric Populations". Journal of Pediatric Pharmacology and Therapeutics 19, n.º 4 (1 de octubre de 2014): 262–76. http://dx.doi.org/10.5863/1551-6776-19.4.262.
Texto completoOvsyankina, E. S., L. V. Panova, E. A. Krushinskaya, O. A. Piskunova y F. G. Poluektova. "ON THE QUESTION OF REDUCED DURATION OF PULMONARY TB TREATMENT IN ADOLESCENTS WITH DRUG SUSCEPTIBILITY DETERMINATION DURING TREATMENT". Вестник ЦНИИТ 7, n.º 2 (2023): 67–72. http://dx.doi.org/10.57014/2587-6678-2023-7-2-67-72.
Texto completoTitov, K. S., E. V. Shutov, A. A. Alimov, S. S. Lebedev, A. A. Kirichek y G. M. Zapirov. "Nephrotoxicity of combination drug therapy in metastatic renal cancer". Cancer Urology 19, n.º 3 (16 de noviembre de 2023): 153–62. http://dx.doi.org/10.17650/1726-9776-2023-19-3-153-162.
Texto completoHarris, Taylor N. y Lindsey R. Buscemi. "Evaluation of treatment simplification strategies in patients living with HIV with multi-drug resistance". Therapeutic Advances in Infectious Disease 10 (enero de 2023): 204993612211498. http://dx.doi.org/10.1177/20499361221149869.
Texto completoKukurika, А. V. "Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis". FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 15, n.º 3 (9 de octubre de 2022): 353–62. http://dx.doi.org/10.17749/2070-4909/farmakoekonomika.2022.131.
Texto completoJames, Lyndon P., Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F. Franke, Reza Yaesoubi, Dumitru Chesov et al. "Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis". PLOS Medicine 21, n.º 5 (3 de mayo de 2024): e1004401. http://dx.doi.org/10.1371/journal.pmed.1004401.
Texto completoBada, Florence O., Nick Blok, Evaezi Okpokoro, Saswata Dutt, Christopher Akolo, Patrick Dakum y Alash’le Abimiku. "Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria". PLOS ONE 15, n.º 12 (1 de diciembre de 2020): e0241065. http://dx.doi.org/10.1371/journal.pone.0241065.
Texto completoKelly, W. K., H. I. Scher, M. Mazumdar, D. Pfister, T. Curley, C. Leibertz, L. Cohen, V. Vlamis, A. Dnistrian y M. Schwartz. "Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer." Journal of Clinical Oncology 13, n.º 9 (septiembre de 1995): 2214–22. http://dx.doi.org/10.1200/jco.1995.13.9.2214.
Texto completoBeelen, DW, K. Quabeck, U. Graeven, HG Sayer, HK Mahmoud y UW Schaefer. "Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]". Blood 74, n.º 5 (1 de octubre de 1989): 1507–16. http://dx.doi.org/10.1182/blood.v74.5.1507.1507.
Texto completoBeelen, DW, K. Quabeck, U. Graeven, HG Sayer, HK Mahmoud y UW Schaefer. "Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia [see comments]". Blood 74, n.º 5 (1 de octubre de 1989): 1507–16. http://dx.doi.org/10.1182/blood.v74.5.1507.bloodjournal7451507.
Texto completoDing, Yajun, Robert Glaubius y Ume Abbas. "Drug Resistance After Failure of WHO Recommended First-Line Antiretroviral Regimen for Adult HIV-1 Infection in South Africa: A Modeling Analysis". Open Forum Infectious Diseases 4, suppl_1 (2017): S424. http://dx.doi.org/10.1093/ofid/ofx163.1067.
Texto completoTaft, David, Tarang Vora, Chen Ren, Patrick S. Zbyszewski, Joseph Morgan, Michael E. Petrone, Steven M. Fruchtman y Manoj Maniar. "Amelioration of Rigosertib Treatment Related Genitourinary (GU) Adverse Events (AEs) in Patients with Myelodysplastic Syndromes: Implementation of Novel Dosing Regimen Derived through Pharmacokinetic Modeling in Phase 2 Study of Oral Rigosertib in Combination with Azacitidine". Blood 132, Supplement 1 (29 de noviembre de 2018): 4379. http://dx.doi.org/10.1182/blood-2018-99-118463.
Texto completoFekadu, Ginenus, Jiaqi Yao y Joyce H. S. You. "Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis". PLOS ONE 17, n.º 8 (5 de agosto de 2022): e0272770. http://dx.doi.org/10.1371/journal.pone.0272770.
Texto completoLiu, Ying, Samyukta Mullangi, Xiaoxue Chen, Timothy Pham, David Joseph Debono, Michael Jordan Fisch, Aliza Gordon y Dawn L. Hershman. "Association between oncology clinical pathway utilization and quality and cost outcomes in patients with metastatic solid tumors." Journal of Clinical Oncology 40, n.º 28_suppl (1 de octubre de 2022): 430. http://dx.doi.org/10.1200/jco.2022.40.28_suppl.430.
Texto completoShang, Shaobin, Crystal A. Shanley, Megan L. Caraway, Eileen A. Orme, Marcela Henao-Tamayo, Laurel Hascall-Dove, David Ackart et al. "Activities of TMC207, Rifampin, and Pyrazinamide againstMycobacterium tuberculosisInfection in Guinea Pigs". Antimicrobial Agents and Chemotherapy 55, n.º 1 (11 de octubre de 2010): 124–31. http://dx.doi.org/10.1128/aac.00978-10.
Texto completoKaufmann, Gilbert R., Nina Khanna, Rainer Weber, Luc Perrin, Hansjakob Furrer, Matthias Cavassini, Bruno Ledergerber et al. "Long-Term Virological Response to Multiple Sequential Regimens of Highly Active Antiretroviral Therapy for HIV Infection". Antiviral Therapy 9, n.º 2 (febrero de 2004): 263–74. http://dx.doi.org/10.1177/135965350400900212.
Texto completoVaughan, William P., Amy G. Nance y Donna E. Salzman. "Improving Dosing Precision in Buslfan (BU) Based Preparative Regimens for Hematopoietic Stem Cell Transplantation (HSCT)." Blood 104, n.º 11 (16 de noviembre de 2004): 1148. http://dx.doi.org/10.1182/blood.v104.11.1148.1148.
Texto completoGray, Adam Thorburn, Liana Macpherson, Ffion Carlin, Bianca Sossen, Alexandra S. Richards, Sandra V. Kik, Rein M. G. J. Houben et al. "Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis". PLOS ONE 18, n.º 11 (16 de noviembre de 2023): e0293535. http://dx.doi.org/10.1371/journal.pone.0293535.
Texto completoSoeny, Kabir, Barbara Bogacka y Byron Jones. "Dose optimisation with simultaneous pharmacokinetic estimation in adaptive clinical trials". Statistical Methods in Medical Research 29, n.º 4 (7 de junio de 2019): 1149–66. http://dx.doi.org/10.1177/0962280219852582.
Texto completoNsengiyumva, Ntwali Placide, Jonathon R. Campbell, Olivia Oxlade, Juan F. Vesga, Christian Lienhardt, Anete Trajman, Dennis Falzon, Saskia Den Boon, Nimalan Arinaminpathy y Kevin Schwartzman. "Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness". PLOS Medicine 19, n.º 6 (13 de junio de 2022): e1004032. http://dx.doi.org/10.1371/journal.pmed.1004032.
Texto completoMcCruden, D. C., T. E. Hilditch, J. M. C. Connell y W. D. Alexander. "Kinetics of [123I]iodide uptake and discharge by perchlorate in studies of inhibition of iodide binding by antithyroid drugs". Acta Endocrinologica 110, n.º 4 (diciembre de 1985): 499–504. http://dx.doi.org/10.1530/acta.0.1100499.
Texto completoChalchal, Hafsah, Vinita Dhir, Kalina Abrol, Michelle Boyce, Michelle Delbaere, Ashish Masurekar, Mike Kennah et al. "Favorable Outcomes with Low Dose Anti Thymocyte Globulin Based Graft Versus Host Disease Prophylaxis after Mismatched Unrelated Donor Allogenic Hematopoietic Cell Transplantation". Blood 142, Supplement 1 (28 de noviembre de 2023): 7002. http://dx.doi.org/10.1182/blood-2023-182274.
Texto completoSiddiqui, Abdul Aziz, Kazi Najamus-saqib Khan, Arafat Ali Farooqui, Muhammad Saad Farooqi, Muhammad Junaid Tariq y Faiz Anwer. "Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review". Blood 134, Supplement_1 (13 de noviembre de 2019): 5574. http://dx.doi.org/10.1182/blood-2019-132095.
Texto completoWinters, Mark A. y Thomas C. Merigan. "Variants Other than Aspartic Acid at Codon 69 of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Gene Affect Susceptibility to Nucleoside Analogs". Antimicrobial Agents and Chemotherapy 45, n.º 8 (1 de agosto de 2001): 2276–79. http://dx.doi.org/10.1128/aac.45.8.2276-2279.2001.
Texto completoHan, Win Min, Wiriya Mahikul, Thomas Pouplin, Saranath Lawpoolsri, Lisa J. White y Wirichada Pan-Ngum. "Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach". PLOS ONE 16, n.º 3 (26 de marzo de 2021): e0248846. http://dx.doi.org/10.1371/journal.pone.0248846.
Texto completoRolsma, Stephanie L., Andrew G. Sokolow, Guohua An, Nick Fishbane, William Fissell, Kenan Gu, Natalia Jimenez et al. "Are We Dosing Correctly? Population Pharmacokinetic Modeling of Cefepime, Piperacillin-Tazobactam, and Meropenem in Individuals with Cystic Fibrosis". Journal of the Pediatric Infectious Diseases Society 12, Supplement_1 (1 de noviembre de 2023): S8. http://dx.doi.org/10.1093/jpids/piad070.015.
Texto completoStone, Chris, Mounir Ait-Khaled, Charles Craig, Philip Griffin y Margaret Tisdale. "Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutation Selection during In Vitro Exposure to Tenofovir Alone or Combined with Abacavir or Lamivudine". Antimicrobial Agents and Chemotherapy 48, n.º 4 (abril de 2004): 1413–15. http://dx.doi.org/10.1128/aac.48.4.1413-1415.2004.
Texto completoFedorin, Andrey Aleksandrovich, Nikolay Alexandrovich Pudovkin, Yulia Rifovna Borodina y Sergey Dmitrievich Klyukin. "Comparative effectiveness of flea allergic dermatitis treatment regimens in dogs and cats". Agrarian Scientific Journal, n.º 8 (10 de septiembre de 2021): 78–81. http://dx.doi.org/10.28983/asj.y2021i8pp78-81.
Texto completoYu, Zaikuan J., Eric P. Mosher y Namandjé N. Bumpus. "Pharmacogenomics of Antiretroviral Drug Metabolism and Transport". Annual Review of Pharmacology and Toxicology 61, n.º 1 (6 de enero de 2021): 565–85. http://dx.doi.org/10.1146/annurev-pharmtox-021320-111248.
Texto completo